Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
Sexual problems among women with multiple sclerosis.
Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.
BAFF maintains T-cell survival by inducing OPN expression in B cells.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement.
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.
Commentary: Never Underestimate the Power of Adenosine in Multiple Sclerosis.
Internal jugular and vertebral vein volume flow in patients with clinically isolated syndrome or mild multiple sclerosis and healthy controls: results from a prospective sonographer-blinded study.
FTY720 for cancer therapy (Review).
Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
Prospective study on retinal nerve fibre layer thickness changes in isolated unilateral retrobulbar optic neuritis.
Multi-parametric representation of voxel-based quantitative magnetic resonance imaging.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.
Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies.
How scientists fool themselves - and how they can stop.
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
More severe manifestations and poorer short-term prognosis of ganglioside-associated guillain-barré syndrome in northeast china.
Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?

Pages